Yinon Ben-Neriah

Title: Innovations of Yinon Ben-Neriah

Introduction

Yinon Ben-Neriah is a notable inventor based in Mevasseret Zion, Israel. He has made significant contributions to the field of pharmaceuticals, holding a total of 11 patents. His work focuses on developing compounds that have therapeutic applications in treating various diseases.

Latest Patents

Among his latest patents is a groundbreaking invention related to heteroaryl compounds and their pharmaceutical compositions. This patent outlines methods for treating, ameliorating, or preventing symptoms of disorders mediated by casein kinase 1 (CK1), interleukin-1 receptor associated kinase (IRAK1), or cyclin-dependent kinase 9 (CDK9). Another significant patent involves pyrazole compounds, which are designed for treating malignant diseases and inflammatory disorders.

Career Highlights

Yinon has worked with prominent organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem and Signal Pharmaceuticals, Inc. His experience in these companies has allowed him to advance his research and development efforts in the pharmaceutical industry.

Collaborations

He has collaborated with esteemed colleagues such as Avraham Yaron and Anthony M. Manning, contributing to the advancement of innovative solutions in his field.

Conclusion

Yinon Ben-Neriah's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through his inventions. His extensive patent portfolio reflects his expertise and dedication to research and development in the medical field.